Indianapolis Motor Speedway announced Monday afternoon that the track has partnered with global pharmaceutical company, Eli Lilly and Company to become the title sponsor of the NASCAR Nationwide Series race. The race, which now will be called the “Lilly Diabetes 250”, is a multi-year deal with Lilly and IMS.
“We’re proud to announce that Lilly is providing the entitlement sponsorship for the Lilly Diabetes 250 Nationwide Series race at IMS. Lilly is an Indianapolis-based company recognized globally as a forerunner in fighting diseases and making lives better for people all over the world, and we greatly look forward to working with them in promoting diabetes awareness during the Lilly Diabetes 250,” Speedway President, J. Douglas Boles said in a statement.
Driver of the No. 16 Ford Fusion, in the Nationwide Series, for Roush Fenway Racing, Ryan Reed, is also sponsored by Lilly, and the American Diabetes Association’s “Drive to Stop Diabetes”. Reed, 20, suffers from Type 1 Diabetes, something that he’s dealt with since age 17.
The Lilly Diabetes 250 NASCAR Nationwide Series race will be held on Saturday, July 26th at historic Indianapolis Motor Speedway.